In-Person Access Only | 6.5 CE/CME Credits
The 2nd Annual NYC Pancreatic Cancer Consortium, held in New York City, will bring together leading experts across disciplines to address the growing clinical and scientific challenges in the management of pancreatic cancer. This symposium is dedicated to advancing a collaborative, multidisciplinary approach to pancreatic oncology, with a focus on improving outcomes through innovation, research, and team-based care.
This year’s program will feature speakers from Cold Spring Harbor, Columbia University Medical Center, Mount Sinai, Stony Brook University, Weill Cornell Medicine, Memorial Sloan Kettering Cancer Center, and NYU Langone, in addition to Northwell.
Conference Agenda
Friday, December 12, 2025
7:30 AM
Coffee and Exhibits
8:00 AM
Program Chair Welcome
Matthew Weiss, MD | Northwell Health Cancer Institute
Session 1: Advancing Early Detection: Pancreatic Cysts, Screening & Risk
Moderators: Vineet Rolston | Memorial Sloan Kettering Cancer Center & Chris Wolfgang | NYU Langone
8:10 AM
General Overview of IPMN and Pancreatic Cysts
Chris DiMaio | Northwell Health Cancer Institute
8:25 AM
IPMN - AI and Diagnostics for Pancreatic Cysts
Wyanne Law | Memorial Sloan Kettering Cancer Center
8:40 AM
Screening Approaches for Patients at High Risk for Pancreatic Cancer
Fay Kastrinos | Columbia University
8:55 AM
Which Pancreatic Cysts Need Surgery
Elliot Newman | Northwell Health Cancer Institute
9:10 AM
Endoscopic and Ablative Therapies for Panreactic Cysts/Tumors
Kartik Sampath | Weill Cornell
9:25 AM
Breakfast and Exhibits
9:40 AM
Non-CME Breakfast - Natera - Using Personalized ctDNA Testing in Pancreatic Adenocarcinoma
Despina Siolas | Weill Cornell
Session 2: Scientific Landscape of Pancreatic Cancer: Drivers, Resistance, and Clinical Implications
Moderators: Manuel Hidalgo | NYU Langone & Dave Tuveson | Cold Spring Harbor Laboratory
10:25 AM
Earlier Detection of Pancreatic Cancer – The Time Is Now
Anirban Maitra | NYU Langone
10:40 AM
Cachexia and PDAC
Tobias Janowitz | Cold Spring Harbor Laboratory
10:55 AM
Molecular Drivers Meet Biologics: HRD and KRAS in PDAC
Wungki Park | Memorial Sloan Kettering Cancer Institute
11:10 AM
Chemoresistance in PDAC
Kenneth Shroyer | Stony Brook University
11:25 AM
Biological and Clinical differences between Kras mutant variants in pancreatic cancer
Despina Siolas | Weill Cornell
Session 3: The Surgical Frontier in Pancreatic Cancer
Moderator: John Chabot | Columbia University & Rohit Chandwani | Weill Cornell
11:40 AM
Robotic Pancreas Surgery
Georgios Georgakis | Stony Brook University
11:55 AM
Surgical Collaboration and PANC-PALS
Ammar Javed | NYU Langone
12:10 PM
Definitions of resectability and approaches to Borderline/Locally Advanced
Lily Saadat | Memorial Sloan Kettering Cancer Center
12:25 PM
Training in Pancreas Surgery
Danielle Deperalta | Northwell Health Cancer Institute
12:40 PM
Surgery for Oligometastatic disease
Noah Cohen | Mount Sinai
Session 4: Redefining Care: The Future of Pancreatic Cancer Therapies
Moderator: Alice Wei | Memorial Sloan Kettering Cancer Center
12:55 PM
Emerging Therapies for PDAC
Nick Hornstein | Northwell Health Cancer Institute
1:15 PM
Liver Versus Lung Organotropism in Pancreas Cancer
Gulam Manji | Columbia University
1:35 PM
Lunch and Exhibits
1:50 PM
Non-CME Lunch - Ipsen -Understanding Options In 1L Metastatic Pancreatic Cancer
Paul Oberstein | NYU Langone
2:35 PM
KEYNOTE ADDRESS: Realizing the Vision: Cancer Vaccines Delivering on Their Clinical Promise
Nilo Azad | Johns Hopkins
3:05 PM
Housekeeping and Survey - Abstract Winner Announcement
Session 5: Connecting Care: Pancreatic Cancer Clinical Trials Across NYC
Moderator: Bud Kroll | Orthogonal Data LLC
3:10 PM
Panel Discussion
Rafi Winograd | NYU Langone
Daniel King | Northwell Health Cancer Institute
Deirdre Cohen | Mt. Sinai
Gulam Manji | Columbia University
Kenneth Yu | Memorial Sloan Kettering Cancer Center
Allyson Ocean | Weill Cornell
1:40 PM
Session 6: Evolving Role of Radiation Therapy in Pancreatic Cancer
Moderator: Karyn Goodman | Mt. Sinai
4:00 PM
New Developments in XRT for pancreas cancer
Marsha Reyngold | Memorial Sloan Kettering Cancer Institute
4:15 PM
XRT Before, During, or After Surgery
Baho Sidiqi | Northwell Health Cancer Institute
Session 7: Strategies for Symptom and Supportive Care in Pancreatic Cancer
Moderator: Tiffany Zavadsky | Northwell Health Cancer Institute
4:30 PM
Enzyme Replacement Therapy
Meghan Rayder | Northwell Health Cancer Institute
4:40 PM
Nutrition
Sabrina Oliver | Columbia University
4:50 PM
Panel Discussion: Chemotherapy Side Effect Management
Katelynne Mugler | Mt. Sinai
Danielle Pinto | Northwell Health Cancer Institute
Karen Chen | Columbia University
Meghan Rayder | Northwell Health Cancer Institute
Shantal Ginsberg | NYU Langone
5:30 PM
Networking Reception
Agenda Subject To Change. All times are EST.
-
Review and analyze advances in the multi-modality treatment of pancreatic cancer including newly available clinical trials.
Identify specific clinical trials available to pancreatic cancer patients at different stages of their disease process.
Describe specific molecular or genetic mutations found in pancreatic cancers that would indicate use of specific medications to treat the disease.
-
In support of improving patient care, this activity has been planned and implemented by Amedco LLC and Total Health. Amedco LLC is jointly accredited by the Accreditation Council for Continuing Medical Education (ACCME), the Accreditation Council for Pharmacy Education (ACPE), and the American Nurses Credentialing Center (ANCC), to provide continuing education for the healthcare team.
Nurses (ANCC) Credit Designation
Amedco LLC designates this activity for a maximum of 6.5 ANCC contact hours.
Physicians (ACCME) Credit Designation
Amedco LLC designates this live activity for a maximum of 6.5 AMA PRA Category 1 CreditsTM. Physicians should claim only the credit commensurate with the extent of their participation in the activity.
Pharmacists and Pharmacy Technicians (ACPE) Credit Designation
Amedco LLC designates this activity for a maximum of 6.5 knowledge-based CPE contact hours.
NOTE to Pharmacists: The only official Statement of Credit is the one you pull from CPE Monitor. You must request your certificate within 30 days of your participation in the activity to meet the deadline for submission to CPE Monitor.
American Board of Internal Medicine (ABIM) MOC Credit
Successful completion of this CME activity, which includes participation in the evaluation component, enables the participant to earn up to 6.5 Medical Knowledge MOC points in the American Board of Internal Medicine's (ABIM) Maintenance of Certification (MOC) program. It is the CME activity provider's responsibility to submit participant completion information to ACCME for the purpose of granting ABIM MOC credit. You must request your certificate within 30 days of the activity to meet the deadline for submission to PARS.
-
Free registration for all healthcare providers
Expert sessions that present the most clinically relevant data, research, and clinical strategies
Real-time discussion and debate
Networking with peers, colleagues, and medical professionals
Access to the latest industry information and resources
Catered meals through-out the program